142 related articles for article (PubMed ID: 17136637)
1. [IGF-I, VEGF and bFGF as predictive factors for the onset of retinopathy of prematurity (ROP)].
Villegas-Becerril E; González-Fernández R; Perula-Torres L; Gallardo-Galera JM
Arch Soc Esp Oftalmol; 2006 Nov; 81(11):641-6. PubMed ID: 17136637
[TBL] [Abstract][Full Text] [Related]
2. Serum erythropoietin, insulin-like growth factor 1, and vascular endothelial growth factor in etiopathogenesis of retinopathy of prematurity.
Yenice O; Cerman E; Ashour A; Firat R; Haklar G; Sirikci O; Akman I; Kazokoglu H
Ophthalmic Surg Lasers Imaging Retina; 2013 Nov; 44(6):549-54. PubMed ID: 24221462
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity.
Löfqvist C; Andersson E; Sigurdsson J; Engström E; Hård AL; Niklasson A; Smith LE; Hellström A
Arch Ophthalmol; 2006 Dec; 124(12):1711-8. PubMed ID: 17159030
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of VEGF and IGF-1 plasma levels in preterm infants--potential correlation with retinopathy of prematurity, clinical implications].
Machalińska A; Modrzejewska M; Dziedziejko V; Kotowski M; Safranow K; Herbowska A; Karczewicz D
Klin Oczna; 2009; 111(10-12):302-6. PubMed ID: 20169883
[TBL] [Abstract][Full Text] [Related]
5. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth.
Hellström A; Engström E; Hård AL; Albertsson-Wikland K; Carlsson B; Niklasson A; Löfqvist C; Svensson E; Holm S; Ewald U; Holmström G; Smith LE
Pediatrics; 2003 Nov; 112(5):1016-20. PubMed ID: 14595040
[TBL] [Abstract][Full Text] [Related]
6. Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity.
Hellgren G; Löfqvist C; Hansen-Pupp I; Gram M; Smith LE; Ley D; Hellström A
Growth Horm IGF Res; 2018 Apr; 39():19-24. PubMed ID: 29274846
[TBL] [Abstract][Full Text] [Related]
7. [Serum IGF-I levels in retinopathy of prematurity. New indications for ROP screening].
Villegas Becerril E; Fernández Molina F; González R; Gallardo Galera JM
Arch Soc Esp Oftalmol; 2005 Apr; 80(4):233-8. PubMed ID: 15852164
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor and insulin-like growth factor-1 in preterm infants with retinopathy of prematurity.
Peirovifar A; Gharehbaghi MM; Gharabaghi PM; Sadeghi K
Singapore Med J; 2013 Dec; 54(12):709-12. PubMed ID: 24356758
[TBL] [Abstract][Full Text] [Related]
9. Retinopathy of prematurity and serum level of insulin-like growth factor-1.
Banjac L; Bokan V
Acta Clin Croat; 2012 Jun; 51(2):209-13. PubMed ID: 23115944
[TBL] [Abstract][Full Text] [Related]
10. The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study.
Kandasamy Y; Hartley L; Rudd D; Smith R
J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2202-2208. PubMed ID: 28573924
[TBL] [Abstract][Full Text] [Related]
11. POSTNATAL SERUM INSULIN-LIKE GROWTH FACTOR I AND RETINOPATHY OF PREMATURITY.
Jensen AK; Ying GS; Huang J; Quinn GE; Binenbaum G
Retina; 2017 May; 37(5):867-872. PubMed ID: 27529840
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity.
Hellgren G; Löfqvist C; Hård AL; Hansen-Pupp I; Gram M; Ley D; Smith LE; Hellström A
Pediatr Res; 2016 Jan; 79(1-1):70-5. PubMed ID: 26372519
[TBL] [Abstract][Full Text] [Related]
13. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity.
Pieh C; Agostini H; Buschbeck C; Krüger M; Schulte-Mönting J; Zirrgiebel U; Drevs J; Lagrèze WA
Br J Ophthalmol; 2008 May; 92(5):689-93. PubMed ID: 18408080
[TBL] [Abstract][Full Text] [Related]
14. Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I.
Löfqvist C; Hansen-Pupp I; Andersson E; Holm K; Smith LE; Ley D; Hellström A
Arch Ophthalmol; 2009 May; 127(5):622-7. PubMed ID: 19433710
[TBL] [Abstract][Full Text] [Related]
15. The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review.
Kandasamy Y; Hartley L; Rudd D; Smith R
Br J Ophthalmol; 2017 Jan; 101(1):21-24. PubMed ID: 27388246
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of IGF1 are a useful predictor of retinopathy of prematurity.
Pérez-Muñuzuri A; Fernández-Lorenzo JR; Couce-Pico ML; Blanco-Teijeiro MJ; Fraga-Bermúdez JM
Acta Paediatr; 2010 Apr; 99(4):519-25. PubMed ID: 20085549
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity.
Kong L; Bhatt AR; Demny AB; Coats DK; Li A; Rahman EZ; Smith OE; Steinkuller PG
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):956-61. PubMed ID: 25613938
[TBL] [Abstract][Full Text] [Related]
18. The Serum Levels of Asymmetric Dimethylarginine, Vascular Endothelial Growth Factor, and Insulin-Like Growth Factor-1 in Preterms with Retinopathy of Prematurity.
Aydoğan S; Dilli D; Kabataş EU; Akduman H; Şah Ipek M; Oğuz B; Ataş N; Zenciroğlu A
Fetal Pediatr Pathol; 2022 Aug; 41(4):634-639. PubMed ID: 34289792
[No Abstract] [Full Text] [Related]
19. Growth factor levels and ROP.
Villegas Becerril E; Gonzalez Fernández R; Fernández Molina F; Gallardo Galera JM
Ophthalmology; 2005 Dec; 112(12):2238. PubMed ID: 16325715
[No Abstract] [Full Text] [Related]
20. Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity.
Wu WC; Lien R; Liao PJ; Wang NK; Chen YP; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC
JAMA Ophthalmol; 2015 Apr; 133(4):391-7. PubMed ID: 25569026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
